These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17936880

  • 1. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M, Giaquinta Romero D, Lazzari M, Calabrese GC.
    Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
    [Abstract] [Full Text] [Related]

  • 2. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP, Zancan P, Peixoto LL, Alves-Sá R, Araújo FS, Mourão PA, Pavão MS.
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological actions of sulodexide.
    Ofosu FA.
    Semin Thromb Hemost; 1998 Nov; 24(2):127-38. PubMed ID: 9579633
    [Abstract] [Full Text] [Related]

  • 4. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC, Alberto MF, Tubio R, Marani MM, Fernández De Recondo ME, Lazzari M, Recondo EF.
    Thromb Res; 2004 Nov; 113(3-4):243-50. PubMed ID: 15140589
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
    Dol F, Petitou M, Lormeau JC, Choay J, Caranobe C, Sie P, Saivin S, Houin G, Boneu B.
    J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
    Dol F, Petitou M, Choay J, Sie P, Houin G, Boneu B.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jan; 116(6):851-7. PubMed ID: 2483702
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological effects of N-alkylamine-labeled low-molecular-mass dermatan sulfate.
    Malsch R, Guerrini M, Berti C, Naggi A, Torri G, Casu B, Harenberg J.
    Semin Thromb Hemost; 1997 Jan; 23(2):99-107. PubMed ID: 9200333
    [Abstract] [Full Text] [Related]

  • 8. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
    Ben Mansour M, Dhahri M, Bertholon I, Ollivier V, Bataille I, Ajzenberg N, Hassine M, Jandrot-Perrus M, Chaubet F, Maaroufi RM.
    Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L, D'Adamo MC, Pawlak K, Polishchuck R, Wollny T, Buczko W, Donati MB.
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
    Dhahri M, Mansour MB, Bertholon I, Ollivier V, Boughattas NA, Hassine M, Jandrot-Perrus M, Chaubet F, Maaroufi RM.
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA, Daniel RA, Desilva K, Seymour RB.
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studies.
    Linhardt RJ, Desai UR, Liu J, Pervin A, Hoppensteadt D, Fareed J.
    Biochem Pharmacol; 1994 Mar 29; 47(7):1241-52. PubMed ID: 8161353
    [Abstract] [Full Text] [Related]

  • 16. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY, Ji SL, Song HF, Ye QN, Cao JC.
    Thromb Res; 2007 Mar 29; 119(3):377-84. PubMed ID: 17097136
    [Abstract] [Full Text] [Related]

  • 17. The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generation.
    Delorme MA, Tam AS, Xu L.
    Thromb Haemost; 1996 May 29; 75(5):747-51. PubMed ID: 8725717
    [Abstract] [Full Text] [Related]

  • 18. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J, Gray E, Weber E, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1989 Feb 28; 61(1):7-9. PubMed ID: 2473537
    [Abstract] [Full Text] [Related]

  • 19. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM, Gamba C, Kordich LC.
    Thromb Res; 2007 Feb 28; 120(5):745-52. PubMed ID: 17270255
    [Abstract] [Full Text] [Related]

  • 20. Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates.
    Pavão MS.
    An Acad Bras Cienc; 2002 Mar 28; 74(1):105-12. PubMed ID: 11960179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.